Contract facts
NONEEMERGENCY PRESCRIPTION ASSISTANCE PROGRAM (EPAP) SUPPORT - OPTION PERIOD IV is a federal NONE award for Aspr/Daappo/Orm Hq held by Express Scripts, Inc. Estimated value —.
EMERGENCY PRESCRIPTION ASSISTANCE PROGRAM (EPAP) SUPPORT - OPTION PERIOD IV
Incumbent footprint
Public recordExpress Scripts, Inc — $1.1B obligated across 49 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50222D00004?
75A50222D00004 (EPAP support) is a Aspr/Daappo/Orm Hq award with an estimated value of —, currently held by Express Scripts, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50222D00004?
Aspr/Daappo/Orm Hq awarded 75A50222D00004 to Express Scripts, Inc.
Who is the incumbent on 75A50222D00004?
Express Scripts, Inc is the incumbent with $1.1B across 49 related awards in SCOUT’s public footprint.
When does Express Scripts, Inc’s 75A50222D00004 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.